FUNDACJA ONKOLOGICZNA "ANTYRAK"
Copy
CopyKey data
Status
KRS number
CopyREGON
CopyNIP/VAT code
CopyVAT registration date
VAT status
Bankruptcy proceedings
FUNDACJA ONKOLOGICZNA "ANTYRAK"
Contacts
Registered address
Copy
Website
-
B
HighReliability
B - HighIncorporation date
21/08/2018Share capital
No dataPrimary activity
Retail sale via mail order houses or via Internet (47.91.Z - PKD 2007)Representatives
0Representatives rights
OŚWIADCZENIE WOLI W IMIENIU FUNDACJI WE WSZYSTKICH SPRAWACH ZA WYJĄTKIEM MAJĄTKOWYCH SKŁADAĆ MOŻE KAŻDY CZŁONEK ZARZĄDU SAMODZIELNIE, 2. W SPRAWACH MAJĄTKOWYCH WYMAGANY JEST PODPIS DWÓCH CZŁONKÓW ZARZĄDU DZIAŁAJĄCYCH ŁĄCZNIE, W TYM PREZESA.Representatives
No representativesBusiness linkages
Premium users: 1.00 credit
Financial report (Okredo)
Premium users: 1.00 credit
People
Representatives
Person  | Title |
|---|---|
- | - |
Persons with Significant Control
Persons with Significant Control
This information is available in our reports and to subscription users.Financial ratios
Net Profit (zł)
11,808Net Profit (zł)
11,808Financial report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (zł) |
| Profit before tax (zł) |
| Net Profit (zł) |
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Liquidity ratioliquidityRatio |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (zł) |
| Current liabilities (zł) |
| Non current liabilities (zł) |
| Non-current Assets (zł) |
| 2022 |
|---|
| 82,161 |
| 36,170 |
| 36,040 |
| 1.00 |
| 2,342.69 |
| 43.87 |
| 114,076 |
| 35 |
| 0 |
| 32,117 |
| 2023 |
|---|
| 120,286 |
| 33,063 |
| 32,959 |
| 1.03 |
| 3,885.69 |
| 27.40 |
| 147,026 |
| 32 |
| 0 |
| 22,717 |
| 2024 |
|---|
| 114,869 |
| 11,891 |
| 11,808 |
| 1.27 |
| 304.28 |
| 10.28 |
| 158,892 |
| 480 |
| 0 |
| - |
| 2024 |
|---|
| 114,869 |
| 11,891 |
| 11,808 |
| 1.27 |
| 304.28 |
| 10.28 |
| 158,892 |
| 480 |
| 0 |
| - |
Turnover (zł)
2024
Turnover (zł)
114,869 zł
-5 % *
Profit before tax (zł)
11,891 zł-64 % *
Net Profit (zł)
11,808 zł-64 % *
Working capital requirement (%)
1.27 
23.30 % *
Liquidity ratio
304.28 -92.17 % *
Net profitability (%)
10.28 %-62.48 % *
Equity (zł)
158,892 zł
8 % *
Current liabilities (zł)
480 zł1,400 % *
Non current liabilities (zł)
0 zł
- *
Non-current Assets (zł)
-Credit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Documents
FUNDACJA ONKOLOGICZNA "ANTYRAK" Documents
Date | Description |
|---|---|
06/07/2025 | OD 01.01.2024 DO 31.12.2024 |
15/06/2024 | OD 01.01.2023 DO 31.12.2023 |
30/06/2023 | OD 01.01.2022 DO 31.12.2022 |
21/08/2022 | OD 01.01.2021 DO 31.12.2021 |
23/09/2021 | OD 01.01.2020 DO 31.12.2020 |